基于网络表型化策略 (NPS) 计算方法的临床数据分析和肝细胞癌患者预后的新方法
Brian Carr1, Patricia Sotáková2, Petr Pancoska3
1Liver Transplantation, Inonu University, Malatya, Türkiye.
概括
网络表型化策略 (NPS) 整合了临床数据,以识别25种肝细胞癌 (HCC) 表型. 这种方法有助于理解HCC生物学,预测瘤生长,并个性化患者死亡率预测.
科学领域:
- 在瘤学瘤学.
- 系统生物学 系统生物学
- 生物信息学是一种生物信息学.
背景情况:
- 肝细胞癌 (HCC) 的进展受到多种因素的影响,但整合这些复杂的相互作用是具有挑战性的.
- 现有的方法很难全面分析影响HCC的多组件关系.
- 需要一种新的方法来更好地了解人类HCC生物学和进展.
研究的目的:
- 引入网络表型化策略 (NPS) 作为一种在HCC进展中整合多组件关系的方法.
- 开发一个新的框架来理解人类HCC生物学.
- 识别不同的HCC表型及其临床影响.
主要方法:
- 将17个标准临床变量 (人口统计,瘤特征,血液学,肝功能测试) 转换为图形理论表示.
- 应用NPS分析患者参数值及其完整的网络关系.
- 用在索引访问中收集的时间连贯数据进行分析.
主要成果:
- 国家医疗系统确定了25种疾病进展顺序的HCC表型.
- 在HCC进展过程中分层的门静脉血栓发生率为5个范围.
- 将患者分为攻击性,缓慢和中等瘤生长亚型.
- 使用25个NPS表型实现了个性化的死亡预测,优化了子队列.
结论:
- 通过整合复杂的临床数据,NPS提供了一种了解HCC生物学的新方法.
- 鉴定的表型为瘤生长模式和血栓形成风险提供了洞察力.
- 开发了一个基于17个临床参数的互联网应用程序,用于基于17个临床参数的个性化患者表型,死亡率和生存率估计.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.0K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
相关概念视频
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Cancer Survival Analysis
308
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
308
